The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH 2017 | Reassuring patients with AML
Compassion and understanding are two key components within medical care. At the International Conference of Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH), Lars Bullinger, MD, from Charité University of Medicine, Berlin, Germany discusses how the chance of recovery for a patient with acute myeloid leukemia (AML) is highly dependent upon their risk profile. Dr Bullinger also encourages optimism and discusses how to reassure patients who suffer from AML.
